Clinical Trial Update: Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated irinotecan for newly diagnosed Ewing sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Sarcoma | Phase 2 | Status: COMPLETED